A new study reports mindfulness group therapy has an equally positive effect for people suffering with depression and anxiety disorders as individual cognitive behavioral therapy.
Like cognitive deficits, psychiatric symptoms such as depression, apathy, and anxiety associated with Alzheimer's disease appear to be a direct consequence of underlying brain changes as a result of increased amyloid-beta accumulation.
Retroviruses may have played a significant role in brain development, a new study reports.
The neuropeptide NPY reduces seizures in human brain tissue.
Researchers report they have discovered where the earliest signs of Alzheimer's may occur in the brain. Initial accumulation of Alzheimer's associated amyloid beta was discovered in an important functional network, the default mode network.
An experiment aimed to investigate how the brain interprets artificial touch sensation from a finger neuroprosthesis, has revealed new information for developing way to measure brain health.
Amyloid-beta accumulates in nerve cells and spreads, from cell to cell, via nerve fibers. This process occurs prior to the formation of amyloid plaques in the brain.
A new blood test to detect biomarkers for Alzheimer's disease is set to undergo trials in the Fall. The test will be able to identify traces of amyloid beta in blood samples with a high degree of accuracy.
Researchers have identified four distinct subtypes of Alzheimer's disease. The findings could lead to more individualized treatments for those with the neurodegenerative disorder.
Researchers at Lund University have developed a new imaging method that can help doctors detect and track Alzheimer's disease in people of different ages more effectively.
Researchers examine the neuroscience behind why we make certain decisions when faced with multiple choices.
New studies may help to explain the path from stem cells to dopamine neurons.
